⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
HUMA News
Humacyte, Inc. Common Stock
Humacyte to Present Third Quarter Financial Results and Provide Business Update on November 12, 2025
globenewswire.com
HUMA
Humacyte Announces Publication of New Data Comparing Symvess™ to Autologous Vein in Extremity Arterial Trauma
globenewswire.com
HUMA
D. Boral Capital Acted as Exclusive Placement Agent to Humacyte (Nasdaq: HUMA) in Connection with its $60,000,000 Registered Direct Offering
accessnewswire.com
HUMA
HUMA
Humacyte Announces Pricing of $60.0 Million Oversubscribed Registered Direct Offering
globenewswire.com
HUMA
Humacyte Announces Publication of Long-Term Results for Ukrainian Patients Treated in Real-World Combat Setting with Symvess™
globenewswire.com
HUMA
Humacyte Announces Expansion of Intellectual Property for Pipeline Products with Granting of New U.S. Patent for Bioengineered Esophagus
globenewswire.com
HUMA